ASX-listed MGC Pharmaceuticals (ASX: MXC) has announced its cannabis derived epilepsy product will now be fully covered by Ireland's Health Service Executive (HSE).CannEpil is...

Australia's Therapeutics Goods Administration (TGA) has warned of the risks of sourcing cannabis products for medicinal purposes via illicit channels.Interest in medical cannabis in...

Australia's Cann Group (ASX: CAN) appears to have experienced a significant setback in its pursuit of registering an over-the-counter cannabidiol (CBD) product.A number of...

New Zealand's Medical Kiwi has fallen afoul of the country's Financial Markets Conduct Act (FMCA) - and is paying the price.NZ's Financial Markets Authority...